Andrew K Balo insider trades

Open-market stock purchases and sales by Andrew K Balo, Director at Glucotrack, Inc, from SEC Form 4 filings since Mar 12, 2010.

Recent trades

DateStockTradeValue
Oct 3, 2025GCTK Glucotrack, IncBought (not open market)—
Oct 3, 2025GCTK Glucotrack, IncBought (not open market)—

Companies traded

  • GCTK Glucotrack, Inc: other filings, last Oct 3, 2025
  • DXCM DexCom Inc: 162 sales, last Mar 10, 2023

Get free alerts when Andrew K Balo files a new trade →